Ireland should consider allowing fully vaccinated to resume normal life, expert says

Ireland Should Consider Allowing Fully Vaccinated To Resume Normal Life, Expert Says
Prof Kingston Mills says the fully vaccinated 'could fill a lot of restaurants safely'. Photo: PA
Share this article

The Government should consider allowing the fully vaccinated population to resume aspects of normal life while the vaccine rollout for younger people is accelerated, one of the State’s leading scientists has said.

Kingston Mills, professor of experimental immunology at Trinity College Dublin, said Ireland should at least consider following the Israeli model which allowed fully vaccinated people to visit restaurants, pubs, cinemas, gyms, theatres and other indoor public spaces at an early stage in its vaccine rollout.


He pointed out that Ireland now has about 40 per cent of the adult population fully vaccinated and said that percentage “could fill a lot of restaurants safely”.

He stressed, however, that one issue might be that staff working in hospitality “tend to be younger, so they would be slightly at risk if they are not vaccinated”.

'Risk equation' of vaccinating young with AstraZen...
Read More

He said opening the country to the fully vaccinated coupled with targeted rapid antigen testing could have benefits.

Speaking on the Brendan O’Connor Show on RTÉ Radio 1, Prof Mills also pointed to fresh international research which has shown that mixing vaccines works, with a “primer” AstraZeneca first dose and a follow-up Pfizer booster producing dramatic results.


He noted the vaccine programme had contained the pandemic and broken the link between infection and hospitalisation and said the key now was to prevent transmission. “Right now the issue is not around hospitalisation, it is among transmission among younger people,” he said.

He said younger people should be offered either the AstraZeneca or the Johnson & Johnson vaccine. He noted that while there were serious clotting incidents linked to both vaccines among younger cohorts, the numbers were “very small, one in a million, [and] I think the benefits outweigh the risk.”

Read More

Message submitting... Thank you for waiting.

Want us to email you top stories each lunch time?

Download our Apps
© 2023, developed by Square1 and powered by